Zobrazeno 1 - 10
of 40
pro vyhledávání: '"N. Mairon"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S L, Silverman, A A, Chines, D L, Kendler, A W C, Kung, C S, Teglbjærg, D, Felsenberg, N, Mairon, G D, Constantine, J D, Adachi, Edward, Zbella
Publikováno v:
Osteoporosis International, 23(1), 351-363. Springer-Verlag London Ltd.
In this 2-year extension of a 3-year study, bazedoxifene showed sustained efficacy in preventing new vertebral fractures in postmenopausal women with osteoporosis and in preventing non-vertebral fractures in higher-risk women. Bazedoxifene significan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf83d1c6a18f1ef005528eb50c1929d
https://doi.org/10.1007/s00198-011-1691-1
https://doi.org/10.1007/s00198-011-1691-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bernhard Hemmer, Jerry S. Wolinsky, Gavin Giovannoni, Carrie Li, Amit Bar-Or, Stephen L. Hauser, N. Mairon, Ludwig Kappos, Jérôme De Seze, Fred D. Lublin
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 88:A46.1-A46
Background Infusion-related reactions (IRRs) have been observed with ocrelizumab treatment. Objective To evaluate the pattern of IRRs in studies of ocrelizumab in relapsing (OPERA I/II [NCT01247324/NCT01412333]) and primary progressive (ORATORIO [NCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6ec02cb6f6df49c36a8c34fa981433e
https://doi.org/10.1136/jnnp-2017-abn.158
https://doi.org/10.1136/jnnp-2017-abn.158
Autor:
Marc K. Drezner, Peter L. Lakatos, J-Y Reginster, Dieter Felsenberg, Paul D. Miller, Claus Christiansen, Cyrus Cooper, Jan J. Stepan, Maria Greenwald, B. Bonvoisin, Pierre D. Delmas, N. Mairon, Lucy Rowell, Ronald Emkey, Silvano Adami, Stuart L. Silverman
Publikováno v:
Annals of the Rheumatic Diseases. 65:654-661
BACKGROUND: Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem. OBJECTIVE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc6dd642229daa4f0f819c36ab45c04
https://doi.org/10.1136/ard.2005.044958
https://doi.org/10.1136/ard.2005.044958
Autor:
B. Bonvoisin, Pierre D. Delmas, David L. Kendler, N. Mairon, Robert R. Recker, M. A. Bolognese, Dieter Felsenberg, Michael R. McClung, J. A. Stakkestad, Paul D. Miller, Jean-Yves Reginster, Cyrus Cooper, Marjorie M. Luckey, Liviu Macovei, E. Michael Lewiecki, C. Hughes
Publikováno v:
Journal of Bone and Mineral Research. 20:1315-1322
Once-monthly (50/50, 100, and 150 mg) and daily (2.5 mg; 3-year vertebral fracture risk reduction: 52%) oral ibandronate regimens were compared in 1609 women with postmenopausal osteoporosis. At least equivalent efficacy and similar safety and tolera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ab7977a0745adeaa1a78e340f0becf8
https://doi.org/10.1359/jbmr.050313
https://doi.org/10.1359/jbmr.050313
Autor:
Jerry S. Wolinsky, Xavier Montalban, Carrie Li, Ludwig Kappos, Jérôme De Seze, N. Mairon, Stephen L. Hauser
Publikováno v:
Revue Neurologique. 173:S118
Introduction Ocrelizumab (OCR) est un anticorps monoclonal humanise ciblant selectivement les lymphocytes B CD20+. Des reactions liees a la perfusion (RLP) ont ete observees apres administration d’OCR. Objectifs Evaluer le profil des IRR dans les e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e968db1787dd2882eca801847e2c826
https://doi.org/10.1016/j.neurol.2017.01.202
https://doi.org/10.1016/j.neurol.2017.01.202
Autor:
Jerry S. Wolinsky, Carrie Li, Peter Chin, N. Mairon, Jérôme De Seze, Stephen L. Hauser, Ludwig Kappos
Publikováno v:
Revue Neurologique. 173:S117
Introduction Un risque accru d’infection avec les traitements de fond de la (SEP) est rapporte. Le taux d’infections est un composant important du profil de tolerance d’ocrelizumab (OCR). Objectifs Evaluer les infections et infections graves ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a961ac5676979d6bedf52ae889fea1
https://doi.org/10.1016/j.neurol.2017.01.200
https://doi.org/10.1016/j.neurol.2017.01.200
Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus
Publikováno v:
European Respiratory Journal. 7:914-920
The objective of this study was to evaluate the potency and efficacy (intrinsic activity) of formoterol and salmeterol and their duration of action in comparison with other beta-adrenoceptor agonists in isolated human bronchi. Human bronchi were obta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a6a525bf1ad82e533471d526800d78c
https://doi.org/10.1183/09031936.94.07050914
https://doi.org/10.1183/09031936.94.07050914
Autor:
T.J. de Villiers, D.L. Kendler, A.A. Chines, P. Lips, J.M. Kaufman, A.B. Levine, N. Mairon, C. Codreanu, D. Felsenberg, J.P. Brown
Publikováno v:
Bone. 47:S198-S199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4d84616a311073d72ca93385094ca66
https://doi.org/10.1016/j.bone.2010.04.469
https://doi.org/10.1016/j.bone.2010.04.469